Market Cap: $127.4B
Market Cap: $127.4B
Open
$21.46
Prev. Close
$33.47
High
$21.67
Low
$21.46
CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China.
CSL Limited trades on the Other OTC under the ticker CSLLY, priced in USD.
CSL Limited has a market capitalisation of $127.4B, based on its latest share price.
CSLLY has no meaningful P/E ratio because it reported a loss over the last 12 months.
Over the past 52 weeks CSLLY has traded between $16.01 and $36.88.
Yes. CSL Limited's dividend yields 2.03% at the current share price.
Loss-making over the last 12 months (net margin -16.1%).
Gordon Naylor DipCompSc is the CEO of CSL Limited, which is headquartered in Melbourne.
Generated automatically from reported financial data. General information only, not financial advice.